Cargando…

Recent Insights into the Pathogenesis of Acute Porphyria Attacks and Increasing Hepatic PBGD as an Etiological Treatment

Rare diseases, especially monogenic diseases, which usually affect a single target protein, have attracted growing interest in drug research by encouraging pharmaceutical companies to design and develop therapeutic products to be tested in the clinical arena. Acute intermittent porphyria (AIP) is on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jericó, Daniel, Córdoba, Karol M., Sampedro, Ana, Jiang, Lei, Joucla, Gilles, Cabanne, Charlotte, Lanciego, José Luis, Martini, Paolo G. V., Berraondo, Pedro, Ávila, Matías A., Fontanellas, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694773/ https://www.ncbi.nlm.nih.gov/pubmed/36430993 http://dx.doi.org/10.3390/life12111858

Ejemplares similares

mRNA-based therapy in a rabbit model of variegate porphyria offers new insights into the pathogenesis of acute attacks
por: Jericó, Daniel, et al.
Publicado: (2021)

High Prevalence of Insulin Resistance in Asymptomatic Patients with Acute Intermittent Porphyria and Liver-Targeted Insulin as a Novel Therapeutic Approach
por: Solares, Isabel, et al.
Publicado: (2021)

Understanding Carbohydrate Metabolism and Insulin Resistance in Acute Intermittent Porphyria
por: Solares, Isabel, et al.
Publicado: (2022)

Mechanistic modelling of enzyme‐restoration effects of new recombinant liver‐targeted proteins in acute intermittent porphyria
por: Vera‐Yunca, Diego, et al.
Publicado: (2022)

Nutritional Interventions with Bacillus coagulans Improved Glucose Metabolism and Hyperinsulinemia in Mice with Acute Intermittent Porphyria
por: Longo, Miriam, et al.
Publicado: (2023)

Acute intermittent porphyria, givosiran, and homocysteine
por: Fontanellas, Antonio, et al.
Publicado: (2021)

Management of hyponatremia associated with acute porphyria—proposal for the use of tolvaptan
por: Solares, Isabel, et al.
Publicado: (2020)

Nuclear distribution of porphobilinogen deaminase (PBGD) in glioma cells: a regulatory role in cancer transformation?
por: Greenbaum, L, et al.
Publicado: (2002)

Biomarkers that predict attacks of acute intermittent porphyria
por: Takata, Tadayuki, et al.
Publicado: (2022)

A regulatory role for porphobilinogen deaminase (PBGD) in delta-aminolaevulinic acid (delta-ALA)-induced photosensitization?
por: Gibson, S. L., et al.
Publicado: (1998)

Renal Failure Affects the Enzymatic Activities of the Three First Steps in Hepatic Heme Biosynthesis in the Acute Intermittent Porphyria Mouse
por: Unzu, Carmen, et al.
Publicado: (2012)

Acute Intermittent Porphyria Attack Triggered by COVID-19 Infection
por: Bardak, Ali Emre, et al.
Publicado: (2023)

Pathogenesis of acute encephalopathy in acute hepatic porphyria
por: Pischik, Elena, et al.
Publicado: (2023)

Health impact of acute intermittent porphyria in latent and non-recurrent attacks patients
por: Buendía-Martínez, Juan, et al.
Publicado: (2021)

Elagolix is porphyrogenic and may induce porphyric attacks in patients with the acute hepatic porphyrias
por: Ma, Christopher D., et al.
Publicado: (2022)

Heme oxygenase-1 inducer hemin does not inhibit SARS-CoV-2 virus infection
por: Maestro, Sheila, et al.
Publicado: (2021)

Diagnosis and Management of Inborn Errors of Metabolism in Adult Patients in the Emergency Department
por: Solares, Isabel, et al.
Publicado: (2021)

Severe neuropathic attack in a woman with acute intermittent porphyria: a case report
por: Huang, Shiqian, et al.
Publicado: (2021)

Implanted Progestin Causing Pain and Psychiatric Disturbances in Porphyria Attack: A Case Report
por: Misek, Ryan K., et al.
Publicado: (2023)

THE PORPHYRIAS
Publicado: (1981)

Acute Intermittent Porphyria in the North of China: The Acute Attack Effect on Quality of Life and Psychological Condition
por: Yang, Jing, et al.
Publicado: (2018)

Patient Perspective on Acute Intermittent Porphyria with Frequent Attacks: A Disease with Intermittent and Chronic Manifestations
por: Simon, Amy, et al.
Publicado: (2018)

Challenges in the management of acute intermittent porphyria with recurrent attacks during pregnancy: A case report
por: Vassiliou, Daphne, et al.
Publicado: (2020)

Long-term management and treatment of acute intermittent porphyria with recurring attacks using pharmacological prophylaxis
por: Kuo, Hung-Chou, et al.
Publicado: (2023)

Acute Porphyria
por: Kernohan, R. J., et al.
Publicado: (1954)

Porphyria revisited.
por: Hurst, L C
Publicado: (1982)

EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks
por: Gouya, Laurent, et al.
Publicado: (2019)

Acute Hepatic Porphyrias: Review and Recent Progress
por: Wang, Bruce, et al.
Publicado: (2018)

Etiologic Factors and Recurrent Attacks of Pellagra
por: Mizell, Geo. C.
Publicado: (1912)

Infectious Mononucleosis and Porphyria
por: Dawson, T. A. J., et al.
Publicado: (1962)

Porphyria and hepatocellular carcinoma
por: Pierach, C.A.
Publicado: (1987)

Acute Hepatic Porphyria
por: Bissell, D. Montgomery, et al.
Publicado: (2015)

Acute intermittent porphyria
por: Syal, Kartik, et al.
Publicado: (2015)

Intermittent Acute Porphyria
por: Macleod, J. G., et al.
Publicado: (1953)

Porphyrias and Mental Handicap
por: Jancar, J.
Publicado: (1978)

Porphyria and kidney diseases
por: Pallet, Nicolas, et al.
Publicado: (2018)

An overview of the cutaneous porphyrias
por: Dawe, Robert
Publicado: (2017)

The Porphyrias: The Royal Purple?
por: Dean, Geoffrey
Publicado: (1970)

Laboratory Diagnosis of Porphyria
por: Di Pierro, Elena, et al.
Publicado: (2021)

Etiology and pathogenesis of the cohesinopathies
por: Zakari, Musinu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rukc9rapo2qct3913knh1a89ch